Apotex Seeking FDA Reconsideration Of Normocarb Drug Designation
This article was originally published in The Gray Sheet
Executive Summary
Apotex wants FDA to designate its Normocarb pre-filter hemofiltration solution as a device instead of a drug in the hope that it can be cleared through the 510(k) process